Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 2,630,901 |
|
|||||
| News | - | ||||||
| Day High | 28.13 | Low High |
|||||
| Day Low | 27.68 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Royalty Pharma PLC | RPRX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.42 | -1.49% | 27.70 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 28.05 | 27.68 | 28.13 | 27.70 | 28.12 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 20,368 | 2,630,901 | US$ 27.98 | US$ 73,618,532 | - | 25.92 - 35.76 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:34:27 | 20 | US$ 27.65 | USD |
Royalty Pharma PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 16.54B | 597.43M | - | 2.35B | 1.13B | 1.90 | 14.57 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Royalty Pharma News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RPRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 27.84 | 28.27 | 27.21 | 28.00 | 3,179,302 | -0.14 | -0.50% |
| 1 Month | 29.96 | 29.96 | 27.21 | 28.44 | 2,724,038 | -2.26 | -7.54% |
| 3 Months | 28.04 | 31.655 | 27.21 | 29.58 | 2,884,806 | -0.34 | -1.21% |
| 6 Months | 26.29 | 31.655 | 26.07 | 28.76 | 2,606,647 | 1.41 | 5.36% |
| 1 Year | 35.01 | 35.76 | 25.92 | 29.53 | 2,459,594 | -7.31 | -20.88% |
| 3 Years | 44.17 | 47.10 | 25.92 | 36.08 | 2,123,766 | -16.47 | -37.29% |
| 5 Years | 45.90 | 57.50 | 25.92 | 38.25 | 2,136,665 | -18.20 | -39.65% |
Royalty Pharma Description
| Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Johnson & Johnson's Tremfya, Gilead's Trodelvy, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates. |
